Global Patent Index - EP 4213708 A1

EP 4213708 A1 20230726 - SYSTEMS AND METHODS FOR MONITORING COMORBIDITIES

Title (en)

SYSTEMS AND METHODS FOR MONITORING COMORBIDITIES

Title (de)

SYSTEME UND VERFAHREN ZUR ÜBERWACHUNG VON KOMORBIDITÄTEN

Title (fr)

SYSTÈMES ET PROCÉDÉS DE SURVEILLANCE DE COMORBIDITÉS

Publication

EP 4213708 A1 20230726 (EN)

Application

EP 21790986 A 20210917

Priority

  • US 202063080344 P 20200918
  • IB 2021058513 W 20210917

Abstract (en)

[origin: WO2022058964A1] A system includes a respiratory therapy system, a memory device, and a control system. The respiratory therapy system includes a respiratory therapy device supplying pressurized air, and a user interface coupled to the respiratory therapy device via a conduit to direct the pressurized air to an airway of a user. The memory device stores machine-readable instructions. The control system includes a processor(s) to execute the machine-readable instructions to: generate data, during a current sleep session, associated with a user of a respiratory therapy system; analyze the generated data to determine a value of a first metric that is associated with a sleep disordered breathing (SDB) condition; analyze the generated data to determine a value of a second metric that is associated with a health condition other than the SDB condition; and based at least in part on the determined value of the second metric, cause an action to be performed.

IPC 8 full level

A61B 5/00 (2006.01); A61B 5/01 (2006.01); A61B 5/021 (2006.01); A61B 5/024 (2006.01); A61B 5/0531 (2021.01); A61B 5/08 (2006.01); A61B 5/087 (2006.01); A61B 5/091 (2006.01); A61B 5/107 (2006.01); A61B 5/11 (2006.01); A61B 5/1455 (2006.01); A61B 5/318 (2021.01); A61B 5/361 (2021.01); A61B 5/363 (2021.01); A61B 5/369 (2021.01); A61M 16/00 (2006.01)

CPC (source: EP US)

A61B 5/0077 (2013.01 - EP); A61B 5/01 (2013.01 - EP); A61B 5/021 (2013.01 - EP); A61B 5/024 (2013.01 - EP); A61B 5/02405 (2013.01 - EP); A61B 5/0531 (2013.01 - EP); A61B 5/0816 (2013.01 - EP); A61B 5/087 (2013.01 - EP); A61B 5/091 (2013.01 - EP); A61B 5/1079 (2013.01 - EP); A61B 5/1118 (2013.01 - EP); A61B 5/1455 (2013.01 - EP); A61B 5/318 (2021.01 - EP); A61B 5/361 (2021.01 - EP); A61B 5/363 (2021.01 - EP); A61B 5/369 (2021.01 - EP); A61B 5/4806 (2013.01 - EP); A61B 5/4818 (2013.01 - US); A61B 5/6887 (2013.01 - US); A61B 5/6891 (2013.01 - EP); A61B 5/6892 (2013.01 - EP); A61M 16/026 (2017.08 - EP); A61M 16/0683 (2013.01 - US); G16H 20/40 (2018.01 - EP); G16H 50/20 (2018.01 - EP); G16H 50/30 (2018.01 - EP); A61M 16/0069 (2014.02 - EP); A61M 21/00 (2013.01 - EP); A61M 2230/04 (2013.01 - EP US); A61M 2230/06 (2013.01 - EP); A61M 2230/205 (2013.01 - EP); A61M 2230/42 (2013.01 - EP US); A61M 2230/60 (2013.01 - EP); A61M 2230/63 (2013.01 - EP)

C-Set (source: EP)

  1. A61M 2230/63 + A61M 2230/005
  2. A61M 2230/42 + A61M 2230/005
  3. A61M 2230/06 + A61M 2230/005
  4. A61M 2230/60 + A61M 2230/005
  5. A61M 2230/04 + A61M 2230/005
  6. A61M 2230/205 + A61M 2230/005

Designated contracting state (EPC)

AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

Designated extension state (EPC)

BA ME

Designated validation state (EPC)

KH MA MD TN

DOCDB simple family (publication)

WO 2022058964 A1 20220324; CN 116490123 A 20230725; EP 4213708 A1 20230726; JP 2023544119 A 20231020; US 2023363700 A1 20231116

DOCDB simple family (application)

IB 2021058513 W 20210917; CN 202180077897 A 20210917; EP 21790986 A 20210917; JP 2023518179 A 20210917; US 202118245528 A 20210917